Mass spectrometric analysis of ubiquitin–platinum interactions of leading anticancer drugs: MALDI versus ESI (Q58858960)

Luigi Messori

4

0 references

Angela Casini

Angela Casini

3

0 references

Paul Dyson

Paul J. Dyson

6

0 references

Christian Hartinger

1

Christian G. Hartinger

0 references

author name string

Bernhard K. Keppler

Journal of Analytical Atomic Spectrometry

5

0 references

publication date

2007

0 references

published in

0 references

volume

22

0 references

issue

8

0 references

page(s)

960-967

0 references

cites work

The origin of macromolecule ionization by laser irradiation (Nobel lecture).

1 reference

Protein and polymer analyses up tom/z 100 000 by laser ionization time-of-flight mass spectrometry

21 January 2018

1 reference

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

21 January 2018

1 reference

Electrospray wings for molecular elephants (Nobel lecture).

21 January 2018

1 reference

Electrospray ionization for mass spectrometry of large biomolecules

21 January 2018

1 reference

Contributions of mass spectrometry to peptide and protein structure

21 January 2018

1 reference

Recent developments in the field of tumor-inhibiting metal complexes.

21 January 2018

1 reference

Toxicity of platinum compounds

21 January 2018

1 reference

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

21 January 2018

1 reference

Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrin

21 January 2018

1 reference

A mass spectrometric and molecular modelling study of cisplatin binding to transferrin

21 January 2018

1 reference

Identification of platination sites on human serum transferrin using 13C and 15N NMR spectroscopy

21 January 2018

1 reference

Cisplatin-protein adducts are efficiently removed by glutathione but not by 5'-guanosine monophosphate

21 January 2018

1 reference

Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines.

21 January 2018

1 reference

Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles

21 January 2018

1 reference

Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins.

21 January 2018

1 reference

Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin

21 January 2018

1 reference

Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide

21 January 2018

1 reference

Exploring Metallodrug–Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome c

21 January 2018

1 reference

Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.

21 January 2018

1 reference

Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(iii) compound with plasma proteins

21 January 2018

1 reference

Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins

21 January 2018

1 reference

Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.

21 January 2018

1 reference

ESI–MS Characterisation of Protein Adducts of Anticancer Ruthenium(II)-Arene PTA (RAPTA) Complexes

21 January 2018

1 reference

Proteomic insights into ubiquitin and ubiquitin-like proteins.

21 January 2018

1 reference

Time-dependent interactions of platinum(II) complexes with 5'-GMP under simulated physiological conditions studies by capillary electrophoresis.

21 January 2018

1 reference

Towards a better understanding of the cisplatin mode of action

21 January 2018

1 reference

Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis

21 January 2018

1 reference

Alkaline hydrolysis of oxaliplatin--isolation and identification of the oxalato monodentate intermediate.

21 January 2018

1 reference

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?

21 January 2018

1 reference